The findings of the present study demonstrated that cirsimaritin-improved insulin resistance is mediated by the activation of the AMPK-GLUT4 pathway in the skeletal and adipose tissues, and by the activation of the AMPK-GLUT2 in the liver. This evidence concerns the gene SLC2A2 and Insulin resistance.